Cracking the China Code for HealthTech; ACTI
5th of July 2019
China is the second largest and fastest growing Medtech and Biotech market. Over the last few years, this has resulted in
increasing investment interest by Chinese Medtech and Biotech into global the health-care and medical research sector.
The ACTI workshop will tangibly provide CEOs and senior Australian executives of medtech and broader healthcare companies the knowledge to help them develop a successful China business strategy. The event will incorporate sessions on developing a market entry strategy; successful partnering approaches; regulatory pathways; distribution and marketing; market risks; common pitfalls; and key success factors for Australian healthcare products, technologies and services into China.